These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 30157053

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
    Aravena C, Yu F, Aldave AJ.
    Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
    [Abstract] [Full Text] [Related]

  • 3. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K, Yu F, Aldave AJ.
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [Abstract] [Full Text] [Related]

  • 4. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R, Weizer JS, de Paula FH, Stein JD, Moroi SE, John D, Musch DC, Mian SI.
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [Abstract] [Full Text] [Related]

  • 5. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
    Aravena C, Bozkurt TK, Yu F, Aldave AJ.
    Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
    [Abstract] [Full Text] [Related]

  • 6. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
    Fadous R, Levallois-Gignac S, Vaillancourt L, Robert MC, Harissi-Dagher M.
    Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
    Noel CW, Isenberg J, Goldich Y, Conlon R, Teichman J, Rubinger DA, Weinberg TA, Slomovic J, Chan CC, Rootman DS, Baig KM, Slomovic AR.
    Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Boston type I keratoprosthesis versus penetrating keratoplasty following a single failed corneal graft.
    El-Khoury J, Khair D, Daoud R, Thompson P, Racine L, Harissi-Dagher M.
    Eye (Lond); 2023 Feb; 37(3):486-491. PubMed ID: 35169272
    [Abstract] [Full Text] [Related]

  • 15. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
    Geoffrion D, Harissi-Dagher M.
    Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
    [Abstract] [Full Text] [Related]

  • 16. Boston type 1 keratoprosthesis for failed keratoplasty.
    Hager JL, Phillips DL, Goins KM, Kitzmann AS, Greiner MA, Cohen AW, Welder JD, Wagoner MD.
    Int Ophthalmol; 2016 Feb; 36(1):73-78. PubMed ID: 25975459
    [Abstract] [Full Text] [Related]

  • 17. Boston type 1 keratoprosthesis: the CHUM experience.
    Robert MC, Harissi-Dagher M.
    Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
    [Abstract] [Full Text] [Related]

  • 18. Boston Keratoprosthesis Outcomes in Severe Ocular Chemical Burns in Southern China: A Retrospective Study.
    Gu J, Zhai J, Zhou S, Chen J.
    Adv Ther; 2016 May; 33(5):760-73. PubMed ID: 27126407
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of Boston keratoprosthesis implantation for failed keratoplasty after keratolimbal allograft.
    Hou JH, de la Cruz J, Djalilian AR.
    Cornea; 2012 Dec; 31(12):1432-5. PubMed ID: 22236785
    [Abstract] [Full Text] [Related]

  • 20. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR, Ang LP, Foster CS, Dohlman CH.
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.